These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 1649132

  • 1. Tolfenamic acid inhibits leukotriene B4-induced chemotaxis of polymorphonuclear leukocytes in vitro.
    Kankaanranta H, Moilanen E, Vapaatalo H.
    Inflammation; 1991 Apr; 15(2):137-43. PubMed ID: 1649132
    [Abstract] [Full Text] [Related]

  • 2. Comparison of in vitro effects of flunixin and tolfenamic acid on human leukocyte and platelet functions.
    Kankaanranta H, Moilanen E, Vapaatalo H.
    Inflammation; 1993 Aug; 17(4):417-25. PubMed ID: 8406686
    [Abstract] [Full Text] [Related]

  • 3. Effects of non-steroidal anti-inflammatory drugs on polymorphonuclear leukocyte functions in vitro: focus on fenamates.
    Kankaanranta H, Moilanen E, Vapaatalo H.
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Dec; 350(6):685-91. PubMed ID: 7708126
    [Abstract] [Full Text] [Related]

  • 4. Tolfenamic acid and leukotriene synthesis inhibition.
    Moilanen E, Kankaanranta H.
    Pharmacol Toxicol; 1994 Dec; 75 Suppl 2():60-3. PubMed ID: 7816785
    [No Abstract] [Full Text] [Related]

  • 5. 15-Hydroxyeicosatetraenoic acid (15-HETE) specifically inhibits LTB4-induced chemotaxis of human neutrophils.
    Ternowitz T, Fogh K, Kragballe K.
    Skin Pharmacol; 1988 Dec; 1(2):93-9. PubMed ID: 2856182
    [Abstract] [Full Text] [Related]

  • 6. Effect of diclofenac sodium, tolfenamic acid and indomethacin on the production of superoxide induced by N-formyl-methionyl-leucyl-phenylalanine in normal human polymorphonuclear leukocytes.
    Friman C, Johnston C, Chew C, Davis P.
    Scand J Rheumatol; 1986 Dec; 15(1):41-6. PubMed ID: 3008321
    [Abstract] [Full Text] [Related]

  • 7. Flufenamic and tolfenamic acids inhibit calcium influx in human polymorphonuclear leukocytes.
    Kankaanranta H, Moilanen E.
    Mol Pharmacol; 1995 May; 47(5):1006-13. PubMed ID: 7746266
    [Abstract] [Full Text] [Related]

  • 8. Orally administered tolfenamic acid inhibits leukotriene synthesis in isolated human peripheral polymorphonuclear leukocytes.
    Moilanen E, Alanko J, Juhakoski A, Vapaatalo H.
    Agents Actions; 1989 Aug; 28(1-2):83-8. PubMed ID: 2551152
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of neutrophil and eosinophil induced chemotaxis by nedocromil sodium and sodium cromoglycate.
    Bruijnzeel PL, Warringa RA, Kok PT, Kreukniet J.
    Br J Pharmacol; 1990 Apr; 99(4):798-802. PubMed ID: 2163279
    [Abstract] [Full Text] [Related]

  • 10. Human monocyte and polymorphonuclear leukocyte chemotactic and chemokinetic responses to leukotriene B4 and FMLP.
    Ternowitz T, Herlin T, Fogh K.
    Acta Pathol Microbiol Immunol Scand C; 1987 Apr; 95(2):47-54. PubMed ID: 3037849
    [Abstract] [Full Text] [Related]

  • 11. Ebselen is a specific inhibitor of LTB4-mediated migration of human neutrophils.
    Patrick RA, Peters PA, Issekutz AC.
    Agents Actions; 1993 Nov; 40(3-4):186-90. PubMed ID: 8023742
    [Abstract] [Full Text] [Related]

  • 12. The effects of ibuprofen and diclofenac on the chemotaxis and adenosine triphosphate level of polymorphonuclear cells in vitro.
    Partsch G, Schwarzer C, Eberl R.
    J Rheumatol; 1990 May; 17(5):583-8. PubMed ID: 2162960
    [Abstract] [Full Text] [Related]

  • 13. Meclofenamate sodium monohydrate inhibits chemotactic factor-induced human polymorphonuclear leukocyte function. A possible explanation for its antiinflammatory effect.
    Perez HD, Elfman F, Marder S.
    Arthritis Rheum; 1987 Sep; 30(9):1023-31. PubMed ID: 2822052
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological profiles of a potential LTB4-antagonist, SM-9064.
    Namiki M, Igarashi Y, Sakamoto K, Nakamura T, Koga Y.
    Biochem Biophys Res Commun; 1986 Jul 31; 138(2):540-6. PubMed ID: 3017332
    [Abstract] [Full Text] [Related]

  • 15. Synthetic leukotriene B4 is a potent chemotaxin but a weak secretagogue for human PMN.
    Rollins TE, Zanolari B, Springer MS, Guindon Y, Zamboni R, Lau CK, Rokach J.
    Prostaglandins; 1983 Feb 31; 25(2):281-9. PubMed ID: 6304818
    [Abstract] [Full Text] [Related]

  • 16. ONO-4057, a novel, orally active leukotriene B4 antagonist: effects on LTB4-induced neutrophil functions.
    Kishikawa K, Tateishi N, Maruyama T, Seo R, Toda M, Miyamoto T.
    Prostaglandins; 1992 Oct 31; 44(4):261-75. PubMed ID: 1332129
    [Abstract] [Full Text] [Related]

  • 17. Specific inhibition of leukotriene B4-induced neutrophil activation by LY223982.
    Jackson WT, Boyd RJ, Froelich LL, Mallett BE, Gapinski DM.
    J Pharmacol Exp Ther; 1992 Dec 31; 263(3):1009-14. PubMed ID: 1335049
    [Abstract] [Full Text] [Related]

  • 18. SC-41930: an inhibitor of leukotriene B4-stimulated human neutrophil functions.
    Tsai BS, Villani-Price D, Keith RH, Zemaitis JM, Bauer RF, Leonard R, Djuric SW, Shone RL.
    Prostaglandins; 1989 Dec 31; 38(6):655-74. PubMed ID: 2561214
    [Abstract] [Full Text] [Related]

  • 19. Feline polymorphonuclear leukocytes respond chemotactically to leukotriene B4 and activated serum but not to F-Met-Leu-Phe.
    Gray GD, Ohlmann GM, Morton DR, Schaub RG.
    Agents Actions; 1986 Jun 31; 18(3-4):401-6. PubMed ID: 3019111
    [Abstract] [Full Text] [Related]

  • 20. Modulation of the heterogeneous membrane potential response of neutrophils to N-formyl-methionyl-leucyl-phenylalanine (FMLP) by leukotriene B4: evidence for cell recruitment.
    Fletcher MP.
    J Immunol; 1986 Jun 01; 136(11):4213-9. PubMed ID: 3009618
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.